Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q1 2023 Earnings Call Transcript May 8, 2023
Akebia Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.14, expectations were $-0.15.
Operator: Good day, and thank you for standing by. Welcome to the Akebia’s First Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. Please be advised that today’s...
